Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AJG555 (Movicol, macrogol 4000) in pediatric chronic constipation
jRCT2080223327Phase 3Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Oct 2016
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of polyethylene glycol in chronic constipation, sponsored by EA Pharma Co., Ltd. Primary endpoint: Change in SBM frequency at Week 2. Started Oct 2016; status: completed.
02
Drugs
polyethylene glycol
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCT2080223327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223327.